Shandong Historical Income Statement

000756 Stock

16.21 0.14 0.87%

Historical analysis of Shandong Xinhua income statement accounts such as Selling General Administrative of 800.1 M, Total Revenue of 6.2 B or Gross Profit of 1.8 B can show how well Shandong Xinhua Pharmaceutical performed in making a profits. Evaluating Shandong Xinhua income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Shandong Xinhua's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Shandong Xinhua Phar latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Shandong Xinhua Phar is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shandong Xinhua Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Shandong Income Statement Analysis

Shandong Xinhua Phar Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Shandong Xinhua shareholders. The income statement also shows Shandong investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Shandong Xinhua Income Statement Chart

The current year's Tax Provision is expected to grow to about 52.1 M, whereas Interest Expense is forecasted to decline to about 38.3 M.

Selling General Administrative Total Revenue Other Operating Expenses Operating Income Net Interest Income Reconciled Depreciation

Total Revenue

Total revenue comprises all receipts Shandong Xinhua Phar generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Shandong Xinhua Phar. It is also known as Shandong Xinhua overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from Shandong Xinhua Phar operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Shandong Xinhua Pharmaceutical is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Net Interest Income

The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.

Most accounts from Shandong Xinhua's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Shandong Xinhua Phar current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shandong Xinhua Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Tax Provision is expected to grow to about 52.1 M, whereas Interest Expense is forecasted to decline to about 38.3 M.

	2021	2022	2023	2024 (projected)
Gross Profit	1.8B	2.0B	2.4B	1.8B
Total Revenue	6.6B	7.5B	8.1B	6.2B

Gross Profit Total Revenue

Shandong Xinhua income statement Correlations

	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Minority Interest	Tax Provision	Net Interest Income	Interest Income	Ebitda	Reconciled Depreciation
Selling General Administrative		0.82	0.86	0.57	0.83	0.83	0.49	0.82	0.78	0.81	0.82	0.77	0.83	0.67	-0.37	0.41	0.81	0.62	0.84	0.78
Total Revenue	0.82		0.98	0.65	0.97	0.99	0.79	0.95	0.99	1.0	0.98	0.92	0.99	0.8	-0.63	0.54	0.93	0.82	0.98	0.96
Gross Profit	0.86	0.98		0.65	0.98	0.99	0.83	0.9	0.95	0.97	0.99	0.94	0.99	0.88	-0.49	0.63	0.91	0.7	0.93	0.9
Other Operating Expenses	0.57	0.65	0.65		0.57	0.64	0.59	0.56	0.63	0.65	0.62	0.46	0.65	0.49	-0.5	0.15	0.79	0.54	0.64	0.61
Operating Income	0.83	0.97	0.98	0.57		0.99	0.79	0.93	0.94	0.96	0.99	0.96	0.98	0.91	-0.45	0.7	0.88	0.7	0.93	0.9
Net Income From Continuing Ops	0.83	0.99	0.99	0.64	0.99		0.82	0.93	0.97	0.98	1.0	0.93	1.0	0.87	-0.54	0.61	0.92	0.75	0.95	0.92
Ebit	0.49	0.79	0.83	0.59	0.79	0.82		0.62	0.75	0.78	0.83	0.82	0.81	0.79	-0.33	0.61	0.69	0.49	0.7	0.68
Research Development	0.82	0.95	0.9	0.56	0.93	0.93	0.62		0.96	0.95	0.91	0.87	0.93	0.72	-0.64	0.45	0.87	0.89	0.98	0.97
Cost Of Revenue	0.78	0.99	0.95	0.63	0.94	0.97	0.75	0.96		1.0	0.95	0.89	0.97	0.75	-0.7	0.49	0.93	0.88	0.98	0.98
Total Operating Expenses	0.81	1.0	0.97	0.65	0.96	0.98	0.78	0.95	1.0		0.97	0.91	0.99	0.78	-0.66	0.52	0.93	0.84	0.98	0.97
Income Before Tax	0.82	0.98	0.99	0.62	0.99	1.0	0.83	0.91	0.95	0.97		0.94	0.99	0.9	-0.5	0.67	0.9	0.7	0.93	0.9
Total Other Income Expense Net	0.77	0.92	0.94	0.46	0.96	0.93	0.82	0.87	0.89	0.91	0.94		0.92	0.88	-0.46	0.74	0.83	0.65	0.88	0.88
Net Income	0.83	0.99	0.99	0.65	0.98	1.0	0.81	0.93	0.97	0.99	0.99	0.92		0.85	-0.56	0.59	0.92	0.76	0.95	0.93
Income Tax Expense	0.67	0.8	0.88	0.49	0.91	0.87	0.79	0.72	0.75	0.78	0.9	0.88	0.85		-0.2	0.89	0.73	0.37	0.7	0.67
Minority Interest	-0.37	-0.63	-0.49	-0.5	-0.45	-0.54	-0.33	-0.64	-0.7	-0.66	-0.5	-0.46	-0.56	-0.2		-0.01	-0.73	-0.82	-0.67	-0.75
Tax Provision	0.41	0.54	0.63	0.15	0.7	0.61	0.61	0.45	0.49	0.52	0.67	0.74	0.59	0.89	-0.01		0.48	0.07	0.41	0.41
Net Interest Income	0.81	0.93	0.91	0.79	0.88	0.92	0.69	0.87	0.93	0.93	0.9	0.83	0.92	0.73	-0.73	0.48		0.77	0.91	0.92
Interest Income	0.62	0.82	0.7	0.54	0.7	0.75	0.49	0.89	0.88	0.84	0.7	0.65	0.76	0.37	-0.82	0.07	0.77		0.9	0.92
Ebitda	0.84	0.98	0.93	0.64	0.93	0.95	0.7	0.98	0.98	0.98	0.93	0.88	0.95	0.7	-0.67	0.41	0.91	0.9		0.99
Reconciled Depreciation	0.78	0.96	0.9	0.61	0.9	0.92	0.68	0.97	0.98	0.97	0.9	0.88	0.93	0.67	-0.75	0.41	0.92	0.92	0.99

Click cells to compare fundamentals

Shandong Xinhua Account Relationship Matchups

Shandong Xinhua income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	55.3M	59.8M	53.1M	49.7M	41.1M	38.3M
Selling General Administrative	893.9M	736.9M	688.9M	814.9M	967.0M	800.1M
Total Revenue	5.6B	6.0B	6.6B	7.5B	8.1B	6.2B
Gross Profit	1.9B	1.8B	1.8B	2.0B	2.4B	1.8B
Other Operating Expenses	63.0M	58.2M	60.3M	59.3M	68.2M	66.0M
Operating Income	458.2M	542.9M	499.0M	543.4M	612.2M	440.3M
Net Income From Continuing Ops	323.1M	347.1M	362.1M	426.3M	506.1M	328.4M
Ebit	361.2M	390.3M	458.8M	403.7M	464.2M	400.3M
Research Development	235.4M	298.3M	341.4M	345.7M	419.2M	276.2M
Cost Of Revenue	3.7B	4.2B	4.8B	5.5B	5.7B	4.5B
Total Operating Expenses	5.1B	5.5B	6.1B	7.0B	7.5B	5.8B
Income Before Tax	381.4M	411.6M	421.2M	471.8M	532.7M	377.6M
Net Income Applicable To Common Shares	255.3M	300.0M	324.9M	348.5M	400.8M	258.3M
Net Income	300.0M	324.9M	348.5M	411.2M	496.5M	311.3M
Income Tax Expense	58.3M	64.5M	59.2M	45.5M	52.3M	51.8M
Minority Interest	141.5M	167.5M	(13.5M)	(15.1M)	(9.6M)	(9.1M)
Tax Provision	58.3M	64.5M	59.2M	45.5M	26.6M	52.1M
Net Interest Income	(56.7M)	(58.9M)	(48.7M)	(42.6M)	(31.8M)	(33.4M)
Interest Income	3.6M	6.0M	8.8M	10.5M	12.3M	7.2M
Ebitda	781.3M	856.8M	908.7M	1.0B	1.2B	887.2M
Reconciled Depreciation	344.6M	385.4M	434.3M	484.8M	513.0M	431.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in Shandong Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Shandong Historical Income Statement

About Shandong Income Statement Analysis

Shandong Xinhua Income Statement Chart

Total Revenue

Other Operating Expenses

Operating Income

Net Interest Income

Shandong Xinhua income statement Correlations

Shandong Xinhua Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Shandong Xinhua income statement Accounts

Also Currently Popular

Other Information on Investing in Shandong Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Total Revenue
Income Before Tax	+ 1.0	Net Income From Continuing Ops
Net Income	+ 1.0	Net Income From Continuing Ops
Total Operating Expenses	+ 1.0	Cost Of Revenue
Net Income From Continuing Ops	+ 0.99	Total Revenue
Cost Of Revenue	+ 0.99	Total Revenue

Interest Income	- 0.82	Minority Interest
Reconciled Depreciation	- 0.75	Minority Interest
Net Interest Income	- 0.73	Minority Interest
Minority Interest	- 0.7	Cost Of Revenue
Ebitda	- 0.67	Minority Interest
Minority Interest	- 0.66	Total Operating Expenses